Frazier taking new company creation angle with $617M fund

Armed with $617M in its Fund X, Frazier to dip its toes in early-stage company creation

For its latest and largest venture fund, Frazier Healthcare Ventures aims to conduct more company creation around novel targets while continuing to focus on its core areas of investment.

The firm will soon begin investing Frazier Life Sciences X, its third fund dedicated solely to life sciences start-ups. The $617 million vehicle is nearly 50% larger than Frazier’s 2017-vintage $419 million Fund IX. Overall, the

Read the full 640 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers